Science, integrity, and investigators' rights: Current challenges

Regulatory Toxicology and Pharmacology

Volumn 24, Issue 1 II, 1996, Pages

  Daniell, William Edward ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Department of Labor and Industries ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; CONFIDENTIALITY; HUMAN; LAW; PRIORITY JOURNAL; RESEARCH; SCIENCE;

BIOMEDICAL AND BEHAVIORAL RESEARCH; BIOMEDICAL RESEARCH; CASE STUDIES; CONSTITUTIONAL LAW; DUE PROCESS; FEDERAL GOVERNMENT; GOVERNMENT REGULATION; INSTITUTIONAL POLICIES; LEGAL APPROACH; OFFICE OF RESEARCH INTEGRITY; RESEARCH INSTITUTES; STANDARDS; UNITED STATES;

BIOMEDICAL RESEARCH; FEDERAL GOVERNMENT; GOVERNMENT REGULATION; SCIENTIFIC MISCONDUCT; UNITED STATES;

EID: 0029946447     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.1996.0091     Document Type: Article

References (30)

1. PHS (U.S. Public Health Service, Department of Health and Human Services) (1989). Responsibilities of awardee and applicant institutions for dealing with and reporting possible misconduct in science: Final rule, 42 CFR Part 50, Subpart A. Fed. Reg. 54, 32446-32451.
2. Price, A. R. (1994). Definitions and boundaries of research misconduct: Perspectives from a federal government viewpoint. J. Higher Educ. 65, 286-297.
3. NSF (National Science Foundation) (1991). 45 CFR Part 689 - Misconduct in Science and Engineering. Fed. Reg. 56(93), 22286-22290.
4. Buzzelli, D. E. (1993). The definition of misconduct: A view from NSF. Science 259, 584-585, 647-648.
5. ORI (Office of Research Integrity; PHS) (1995). ORI Newsletter (March), Vol. 3(2).
6. Broad, W., and Wade, N. (1982). Ch 2: Deceit in History, and Appendix: Known or Suspected Cases of Scientific Fraud. In Betrayers of the Truth, pp. 22-37, 225-232. Simon & Schuster, NY.
7. Marsa, L. (1992). Scientific fraud. Omni 14(9), 38+.
8. Woolf, P. K. (1988). Deception in scientific research. Jurimetr. J. 29, 67-95.
9. Hixson, J. (1976). The Patchwork Mouse. Anchor, NY.
10. LaFollette, M. C. (1994). The pathology of research fraud: The history and politics of the US experience. J. Intern. Med. 235, 129-135.
11. LaFollette, M. C. (1994). The politics of research misconduct: Congressional oversight, universities, and science. J. Higher Educ. 65, 261-285.
12. Price, A. R. (1994). Definitions and boundaries of research misconduct: Perspectives from a federal government viewpoint. J. Higher Educ. 65, 286-297.
13. Rennie, D., and Gunsalus, C. K. (1993). Scientific misconduct: New definition, procedures, and office - Perhaps a new leaf. JAMA 269, 915-917.
14. NIH (National Institutes of Health; PHS) (1986). Interim policies and procedures for dealing with possible misconduct in science. NIH Guide for Grants and Contracts. July 18, 1986, pp. 1-37 (per Price, A. R., Ref. 2).
15. PHS (1990). Misconduct in science: Notice of availability (policies and procedures for dealing with and reporting possible misconduct in extramural research). Fed. Reg. 55, 42490.
16. PHS (1989). NIH Scientific Integrity Office established: PHS. Fed. Reg. 54, 11080.
17. NSF (1987). 45 CFR Part 689 - Misconduct in science and engineering. Fed. Reg. 52, 4158-4161.
18. Anon (1992). James H. Abbs and Board of Regents of the University of Wisconsin System, plaintiffs-appellants, cross-appellees v. Louis W. Sullivan, Secretary of the Department of Health and Human Services, et al., defendants-appellees, cross-appellees. Nos. 91-1923, 91-1924, and 91-2149. United States Court of Appeals, Seventh Circuit. Federal Reporter, 2nd Series, Vol. 963, pp. 918-929.
19. PHS (1991). Policies and procedures for dealing with and reporting possible misconduct in extramural research. Fed. Reg. 56(114), 27384-27394.
20. PHS (1992). Public Health Service: Statement of organization, functions and delegations of authority. Fed. Reg. 57(110), 24262-24263.
21. PHS (1992). Opportunity for a hearing on Office of Research Integrity scientific misconduct findings. Fed. Reg. 57(216), 53125-53126.
22. ORI (1993). Research grant application integrity checklist [draft]. ORI Newsletter, Vol. 1(3).
23. ORI (1993). Position Paper #1: The Whistleblower's Conditional Privilege to Report Allegations of Scientific Misconduct. ORI, Washington, DC.
24. NIH (1995). Responsibilities of NIH and awardee institutions for the responsible conduct of research. NIH Guide 1994; 23(42) and 23(44). Clarified in 1995; 24(9).
25. ORI (1994). ORI conducting compliance reviews. ORI Newsletter, Vol. 2(2).
26. ORI (1994). ORI acting to protect whistleblowers. ORI Newsletter, Vol. 2(4).
27. ORI (1994). Misconduct model policy and model instructions developed. ORI Newsletter, Vol. 3(1).
28. PHS (1995). Objectivity in research. NIH Guide July 14, 1995; 24(25).
29. ORI (1995). Guidelines developed on whistleblower protection. ORI Newsletter, Vol. 3(3).
30. Commission on Research Integrity (1995). Integrity and Misconduct in Research: Report of the Commission on Research Integrity to the Secretary of Health and Human Services, the House Committee on Commerce, and the Senate Committee on Labor and Human Resources. DHHS, Washington, DC.